Literature DB >> 23504808

Vitamin D and nonalcoholic fatty liver disease (NAFLD): is it more than just an association?

Ryan M Kwok1, Dawn M Torres, Stephen A Harrison.   

Abstract

Vitamin D is a secosteroid with known effects on calcium homeostasis that has recently been shown to have other significant functions regarding immune modulation, cell differentiation and proliferation, and the inflammatory response. As our understanding of the many functions of vitamin D has grown, the presence of vitamin D deficiency (VDD) has become more evident in Western populations. Concomitantly, nonalcoholic fatty liver disease (NAFLD) has become the most common cause of chronic liver disease. NAFLD and VDD are often found together, and while this is not unexpected, given their similar associations with obesity and sedentary lifestyle, a growing body of evidence points to a closely linked and potentially causative relationship between VDD and NAFLD. The epidemiologic association between VDD and NAFLD as well as the role of VDD in the pathogenesis of NAFLD and the available evidence on the clinical utility of vitamin D replacement in NAFLD populations are discussed.
© 2013 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23504808     DOI: 10.1002/hep.26390

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  45 in total

1.  Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: results from a meta-analysis.

Authors:  Xiang Wang; Weiping Li; Ying Zhang; Yang Yang; Guijun Qin
Journal:  Int J Clin Exp Med       Date:  2015-10-15

Review 2.  Metabolic syndrome: A review of the role of vitamin D in mediating susceptibility and outcome.

Authors:  Richard C Strange; Kate E Shipman; Sudarshan Ramachandran
Journal:  World J Diabetes       Date:  2015-07-10

3.  Identification of unique glycoisoforms of vitamin D-binding protein and haptoglobin as biomarker candidates in hepatocarcinogenesis of STAM mice.

Authors:  Yasunobu Yoshida; Jun-Ichi Furukawa; Shoichi Naito; Kenichi Higashino; Yoshito Numata; Yasuro Shinohara
Journal:  Glycoconj J       Date:  2018-09-08       Impact factor: 2.916

4.  Vitamin D is Not Associated With Severity in NAFLD: Results of a Paired Clinical and Gene Expression Profile Analysis.

Authors:  Yuval A Patel; Ricardo Henao; Cynthia A Moylan; Cynthia D Guy; Dawn L Piercy; Anna Mae Diehl; Manal F Abdelmalek
Journal:  Am J Gastroenterol       Date:  2016-09-20       Impact factor: 10.864

Review 5.  Dietary and metabolic modulators of hepatic immunity.

Authors:  Antonella Carambia; Johannes Herkel
Journal:  Semin Immunopathol       Date:  2017-11-06       Impact factor: 9.623

6.  Severe Vitamin D Deficiency Is Not Associated with Liver Damage in Morbidly Obese Patients.

Authors:  Rodolphe Anty; Audrey Hastier; Clémence M Canivet; Stéphanie Patouraux; Anne-Sophie Schneck; Patricia Ferrari-Panaia; Imed Ben-Amor; Marie Christine Saint-Paul; Jean Gugenheim; Philippe Gual; Antonio Iannelli; Albert Tran
Journal:  Obes Surg       Date:  2016-09       Impact factor: 4.129

7.  Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.

Authors:  Lingyun Ma; Masatoshi Ishigami; Takashi Honda; Shinya Yokoyama; Kenta Yamamoto; Yoji Ishizu; Teiji Kuzuya; Kazuhiko Hayashi; Yoshiki Hirooka; Hidemi Goto
Journal:  Dig Dis Sci       Date:  2019-03-02       Impact factor: 3.199

Review 8.  Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer.

Authors:  Abigale Lade; Luke A Noon; Scott L Friedman
Journal:  Curr Opin Oncol       Date:  2014-01       Impact factor: 3.645

9.  Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats.

Authors:  Giovanna Mazzone; Carmine Morisco; Vincenzo Lembo; Giuseppe D'Argenio; Maria D'Armiento; Antonella Rossi; Carmine Del Giudice; Bruno Trimarco; Nicola Caporaso; Filomena Morisco
Journal:  United European Gastroenterol J       Date:  2018-05-17       Impact factor: 4.623

10.  A clinical model to predict fibrosis on liver biopsy in paediatric subjects with nonalcoholic fatty liver disease.

Authors:  Sakil Kulkarni; Nadia Naz; Hongjie Gu; Janis M Stoll; Michael D Thompson; Brian J DeBosch
Journal:  Clin Obes       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.